Northwestern University School of Medicine

Chicago, Illinois 60619

1 studies enrolling now · 15 studies all time

What they study most

Atopic Dermatitis, Carcinoma, Hepatocellular, Combined Pulmonary Fibrosis and Emphysema, Crohn's Disease, Eosinophilic Disorder, Eosinophilic Esophagitis, Eosinophilic Gastrointestinal Disorders (EGID), Interstitial Lung Disease, Lung Cancer, Lupus Erythematosus, Systemic, Major Depressive Disorder, Outcomes

Studies at this site

• TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection — Completed
• Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer — Enrolling by invitation
• Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer — Completed
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE — Completed
• Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease — Completed
• Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 — Completed
• Registry for Eosinophilic Gastrointestinal Disorders (REGID) — Completed
• The Chimerix CMX001 Registry — Stopped early
• A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021 — Completed
• Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. — Completed
• Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder — Completed
• Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands — Completed
• Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed
• Combination Therapy for Atopic Dermatitis — Completed